Skip links

Intellectual Property, Down to a Science

Contact Us
Gallium Law

Guides

Navigating PTAB Challenges in Medical Device Patents

Schedule Consultation
Get In Touch

651-256-9480

Table of Contents

The Patent Trial and Appeal Board (PTAB) has become a critical battleground for medical device patent holders. Since its establishment under the America Invents Act (AIA), the PTAB has created both opportunities and risks for innovators in the medical device industry. Understanding how to navigate PTAB proceedings can mean the difference between maintaining valuable patent protection and losing critical intellectual property rights.

At Gallium Law, we help medical device companies defend their innovations against PTAB challenges while leveraging strategic opportunities to challenge competitor patents. This guide provides essential insights into PTAB proceedings and practical strategies for protecting your medical device patents.

Understanding the PTAB and Its Role

The Patent Trial and Appeal Board serves as a judicial body within the United States Patent and Trademark Office (USPTO). The PTAB reviews patentability challenges and hears appeals from adverse patent examiner decisions. For medical device companies, the PTAB represents an alternative to federal court litigation for resolving patent disputes.

Why PTAB Proceedings Matter for Medical Device Companies

Medical device patents face unique vulnerabilities in PTAB proceedings. The combination of complex prior art landscapes, evolving standards of care, and extensive scientific literature creates multiple avenues for challengers to attack a patent’s validity. Additionally, the PTAB’s lower burden of proof compared to federal courts, makes it an attractive forum for competitors seeking to invalidate patents.

Types of PTAB Proceedings

Several types of PTAB proceedings can impact medical device patents. Each has distinct characteristics, timelines, and strategic considerations.

Inter Partes Review (IPR)

Inter Partes Review is the most common PTAB proceeding. IPR allows third parties to challenge issued patents based on prior art patents and printed publications. The proceeding typically concludes within 12 to 18 months, making it faster than traditional litigation.

For medical device patents, IPR petitions often cite scientific literature, earlier patent applications, and regulatory submissions as prior art. Patent owners must be prepared to distinguish their inventions from a broad universe of technical disclosures.

Post-Grant Review (PGR)

Post-Grant Review provides a broader range of invalidity grounds but is only available for patents filed under the AIA and must be filed within nine months of patent grant. PGR allows challenges based on any ground of invalidity, including patent eligibility under Section 101, which has particular relevance for diagnostic and software-related medical device patents.

Common Vulnerabilities in Medical Device Patents

Medical device patents face several recurring challenges in PTAB proceedings that patent holders should anticipate.

Obviousness Challenges

Most PTAB challenges against medical device patents allege obviousness under 35 U.S.C. § 103. Petitioners often combine multiple prior art references to challenge a patent’s validity by arguing that the combination of the prior art references would have been obvious to a person of ordinary skill in the art and that the claimed invention is not patentable. Given the iterative nature of medical device development, challengers can frequently identify incremental improvements in the prior art.

Prior Art from Multiple Sources

Medical device patents must withstand scrutiny from diverse prior art sources including patent literature, scientific publications, regulatory submissions, conference presentations, and even product manuals. The duty of disclosure during patent prosecution requires applicants to submit material prior art, but challengers often uncover additional references during PTAB proceedings.

Written Description and Enablement Issues

Complex medical devices with multiple components or sophisticated mechanisms may face challenges regarding whether the patent specification adequately describes and enables the claimed invention. These challenges become particularly acute when patent claims are broadly drafted or when the specification lacks detailed working examples.

Strategic Considerations Before and During PTAB Proceedings

Successful navigation of PTAB challenges requires proactive planning and strategic decision-making throughout the patent lifecycle.

Prosecution Strategies to Minimize PTAB Risk

Strong patent prosecution practices can reduce vulnerability to PTAB challenges. Building a robust prosecution record by drafting a comprehensive disclosure, submitting key prior art references via Information Disclosure Statements to be reviewed by the examiner, and presenting well-supported claim amendments creates a stronger foundation for defending against future challenges.

Exercise caution when submitting prior art characterizations or arguments to the USPTO. Statements made during prosecution become a permanent part of the file wrapper and can be used against you in future PTAB or district court proceedings. Inadvertent admissions can narrow claim scope or create obviousness vulnerabilities that are difficult to overcome. To preserve patent validity and breadth, precision and restraint are essential.

When securing patents for medical devices, consider how claims may be interpreted during PTAB proceedings. Claim construction at the PTAB follows the broadest reasonable interpretation standard for pre-AIA patents and the ordinary plain meaning standard for AIA patents, which can significantly impact validity determinations.

Portfolio Management and Risk Assessment

Effective portfolio management includes identifying which patents face the highest PTAB risk. Patents covering core technologies, those asserted in licensing negotiations, or those blocking competitor market entry become targets for PTAB challenges.

Conducting regular due diligence reviews of your patent portfolio helps identify potential weaknesses before competitors discover them. This proactive approach allows you to address vulnerabilities through continuation applications, reissue proceedings, or strategic claim amendments.

Defending Against PTAB Challenges

When facing a PTAB challenge, medical device patent owners have several defensive strategies available.

Preliminary Response Strategy

Patent owners can file a preliminary response to an IPR or PGR petition before the PTAB decides whether to institute proceedings. A well-crafted preliminary response can persuade the PTAB that the petitioner has not met the threshold for instituting review, effectively ending the challenge before it begins.

Claim Amendment Opportunities

The PTAB allows patent owners to amend claims during proceedings through motions to amend. While historically difficult to successfully amend claims, recent guidance has made this process more accessible. Strategic claim amendments can overcome prior art combinations while preserving patent scope.

Expert Testimony and Evidence

Expert declarations play a crucial role in PTAB proceedings. Medical device patents often require testimony from physicians, engineers, or other specialists who can explain the technical merits of the invention and why prior art combinations would not have been obvious. Selecting the right experts and preparing compelling declarations strengthens your defense.

Leveraging PTAB Proceedings Offensively

PTAB proceedings also provide opportunities to challenge competitor patents that may block your freedom to operate or create marketplace barriers.

Identifying Vulnerable Competitor Patents

Licensing and strategy planning should include analysis of competitor patent portfolios. PTAB proceedings offer a cost-effective mechanism to eliminate problematic patents that might otherwise require expensive federal court litigation to address. 

Coordination with Business Objectives

PTAB challenges should align with broader business goals. Timing petitions to coincide with product launches, licensing negotiations, or market entry can maximize strategic impact while minimizing costs compared to traditional litigation.

Working with Experienced PTAB Counsel

The specialized nature of PTAB proceedings requires counsel with specific expertise in both patent law and the medical device industry. At Gallium Law, our team combines deep technical knowledge with proven PTAB experience to help clients navigate these complex proceedings.

What to Look for in PTAB Representation

Effective PTAB representation requires understanding both the technical aspects of medical device innovation and the procedural nuances of PTAB practice. Look for counsel who can explain complex medical technology clearly, identify strategic opportunities and risks, and craft compelling legal and technical arguments.

Our comprehensive services include PTAB defense, offensive challenges, and strategic counseling to minimize PTAB risks during patent prosecution and portfolio development.

Protecting Your Medical Device Innovations: Your Next Steps

PTAB proceedings have fundamentally changed the landscape for medical device patent protection. While these proceedings create risks, they also offer strategic opportunities for both defending valuable patents and challenging problematic competitor rights. Success requires proactive planning, strategic decision-making, and experienced counsel who understand both the technical and legal complexities involved.

Whether you are defending against a PTAB challenge, considering filing a petition against a competitor’s patent, or want to minimize future PTAB risks, Gallium Law can help. Our team has extensive experience navigating PTAB proceedings for medical device companies of all sizes.

Contact us today to schedule a free consultation to discuss how we can help protect your medical device innovations and develop a comprehensive strategy for managing PTAB risks and opportunities.